(0.26%) 5 309.25 points
(0.30%) 38 906 points
(0.31%) 18 648 points
(-0.08%) $76.93
(4.33%) $2.70
(-0.17%) $2 341.70
(-0.23%) $30.37
(0.42%) $1 046.40
(0.02%) $0.922
(0.02%) $10.49
(-0.03%) $0.785
(-0.47%) $90.01
Live Chart Being Loaded With Signals
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally...
Stats | |
---|---|
Today's Volume | 25 629.00 |
Average Volume | 13 216.00 |
Market Cap | 4.47M |
EPS | $0 ( 2024-05-02 ) |
Last Dividend | $0.850 ( 2022-12-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.271 |
ATR14 | $0.0230 (0.97%) |
Medigus Ltd. Correlation
10 Most Positive Correlations | |
---|---|
GNOG | 0.849 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Medigus Ltd. Financials
Annual | 2023 |
Revenue: | $91.72M |
Gross Profit: | $11.84M (12.91 %) |
EPS: | $-9.50 |
FY | 2023 |
Revenue: | $91.72M |
Gross Profit: | $11.84M (12.91 %) |
EPS: | $-9.50 |
FY | 2022 |
Revenue: | $91.86M |
Gross Profit: | $14.45M (15.73 %) |
EPS: | $-6.28 |
FY | 2021 |
Revenue: | $10.12M |
Gross Profit: | $4.80M (47.45 %) |
EPS: | $3.00 |
Financial Reports:
No articles found.
Medigus Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.850 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.850 | 2022-12-19 |
Last Dividend | $0.850 | 2022-12-19 |
Next Dividend | $0 | N/A |
Payout Date | 2022-12-28 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.850 | -- |
Avg. Dividend % Per Year | 0.87% | -- |
Score | 0.36 | -- |
Div. Sustainability Score | 0.429 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2022 | $0.850 | 5.20% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
OXLC | Dividend Diamond | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend Royal | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.135 | 1.500 | -2.70 | -4.05 | [0 - 0.5] |
returnOnAssetsTTM | -0.292 | 1.200 | -9.75 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.592 | 1.500 | -7.69 | -10.00 | [0.1 - 1] |
payoutRatioTTM | -0.151 | -1.000 | -1.510 | 1.510 | [0 - 1] |
currentRatioTTM | 1.082 | 0.800 | 9.59 | 7.67 | [1 - 3] |
quickRatioTTM | 0.963 | 0.800 | 9.04 | 7.23 | [0.8 - 2.5] |
cashRatioTTM | 0.320 | 1.500 | 9.33 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.153 | -1.500 | 7.45 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -4.72 | 1.000 | -2.86 | -2.86 | [3 - 30] |
operatingCashFlowPerShareTTM | -4.67 | 2.00 | -1.557 | -3.11 | [0 - 30] |
freeCashFlowPerShareTTM | -5.75 | 2.00 | -2.88 | -5.75 | [0 - 20] |
debtEquityRatioTTM | 0.415 | -1.500 | 8.34 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.150 | 1.000 | -0.833 | -0.833 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0864 | 1.000 | -3.73 | -3.73 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.779 | 1.000 | -5.44 | -5.44 | [0.2 - 2] |
assetTurnoverTTM | 2.17 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 0.429 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.206 | 1.000 | -0.122 | 0 | [1 - 100] |
returnOnEquityTTM | -0.592 | 2.50 | -4.94 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -5.75 | 2.00 | -1.918 | -5.75 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -4.67 | 2.00 | -1.557 | -3.11 | [0 - 30] |
payoutRatioTTM | -0.151 | 1.500 | -1.510 | 1.510 | [0 - 1] |
pegRatioTTM | -0.00176 | 1.500 | -3.35 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0551 | 1.000 | -3.88 | 0 | [0.1 - 0.5] |
Total Score | -2.82 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Medigus Ltd.
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators